Online First

FEBRUARY 26, 2020

FDA Approves First IV Preventive Migraine Treatment

A new preventive therapy for migraine in adults has been approved by the FDA. Intravenously administered, Vyepti (eptinezumab-jjmr, Lundbeck) will be available in April 2020.

Related Content

Noninvasive VNS Shown Effective For

To read the full story, Log in or Sign up for a Free Account

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select